Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Published Online
on September 17, 2007

Hypertension. 2007
Published online before print September 17, 2007, doi: 10.1161/HYPERTENSIONAHA.107.091058
A more recent version of this article appeared on November 1, 2007
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
50/5/877    most recent
HYPERTENSIONAHA.107.091058v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nagase, M.
Right arrow Articles by Fujita, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nagase, M.
Right arrow Articles by Fujita, T.
Related Collections
Right arrow Other hypertension
Right arrow Obesity
Right arrow Other Treatment
Right arrow Animal models of human disease
Right arrowRelated Article

Submitted on March 23, 2007
Revised on April 11, 2007

Salt-Induced Nephropathy in Obese Spontaneously Hypertensive Rats Via Paradoxical Activation of the Mineralocorticoid Receptor. Role of Oxidative Stress

Miki Nagase*; Hiromitsu Matsui; Shigeru Shibata; Takanari Gotoda; and Toshiro Fujita

From the Departments of Nephrology and Endocrinology (M.N., H.M., S.S., T.G., T.F.) and Clinical and Molecular Epidemiology, 22nd Century Medical and Research Center (M.N., T.G.), University of Tokyo Graduate School of Medicine, Japan.

* To whom correspondence should be addressed. E-mail: mnagase-tky{at}umin.ac.jp.

Abstract—Aldosterone is implicated in the pathogenesis of proteinuria and chronic kidney disease. We previously demonstrated the contribution of elevated serum aldosterone in the early nephropathy of SHR/NDmcr-cp (SHR/cp), a rat model of metabolic syndrome. In the present study, we investigated the effect of salt loading on renal damage in SHR/cps and explored the underlying mechanisms. SHR/cps fed a high-sodium diet for 4 weeks developed severe hypertension, massive proteinuria, and advanced renal lesions. High salt also worsened glomerular podocyte impairment. Surprisingly, selective mineralocorticoid receptor (MR) antagonist eplerenone dramatically ameliorated the salt-induced proteinuria and renal injury in SHR/cps. Although salt loading reduced circulating aldosterone, it increased nuclear MR and expression of aldosterone effector kinase Sgk1 in the kidney. Gene expressions of transforming growth factor-{beta}1 and plasminogen activator inhibitor-1 were also enhanced in the kidneys of salt-loaded SHR/cps, and eplerenone completely inhibited these injury markers. To clarify the discrepancy between decreased aldosterone and enhanced MR signaling by salt, we further investigated the role of oxidative stress, a putative key factor mediating salt-induced tissue damage. Interestingly, antioxidant Tempol attenuated the salt-evoked MR upregulation and Sgk1 induction and alleviated proteinuria and renal histological abnormalities, suggesting the involvement of oxidative stress in salt-induced MR activation. MR activation by salt was not attributed to increased serum corticosterone or reduced 11{beta}-hydroxysteroid dehydrogenase type 2 activity. In conclusion, sodium loading exacerbated proteinuria and renal injury in metabolic syndrome rats. Salt reduced circulating aldosterone but caused renal MR activation at least partially via induction of oxidative stress, and eplerenone effectively improved the nephropathy.


Key words: aldosterone • mineralocorticoids • metabolic syndrome • sodium • dietary • oxidative stress (kidney) • chronic kidney disease • proteinuria • eplerenone


Related Article:

Mineralocorticoid Receptor Activation and Oxidative Stress
John W. Funder
Hypertension 2007 50: 840-841. [Full Text] [PDF]



This article has been cited by other articles:


Home page
HypertensionHome page
H. Matsui, K. Ando, H. Kawarazaki, A. Nagae, M. Fujita, T. Shimosawa, M. Nagase, and T. Fujita
Salt Excess Causes Left Ventricular Diastolic Dysfunction in Rats With Metabolic Disorder
Hypertension, August 1, 2008; 52(2): 287 - 294.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. M. C. Connell, S. M. MacKenzie, E. M. Freel, R. Fraser, and E. Davies
A Lifetime of Aldosterone Excess: Long-Term Consequences of Altered Regulation of Aldosterone Production for Cardiovascular Function
Endocr. Rev., April 1, 2008; 29(2): 133 - 154.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. W. Funder
Mineralocorticoid Receptor Activation and Oxidative Stress
Hypertension, November 1, 2007; 50(5): 840 - 841.
[Full Text] [PDF]